Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkersGiovanni B. Frisoni, Bengt Winblad, Marina Boccardi et al.|The Lancet Neurology|2017Cited by 630
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Alexander Drzezga, Javier Arbizu et al.|The Lancet Neurology|2020Cited by 535
Quantification of amyloid PET for future clinical use: a state-of-the-art reviewHugh Pemberton, Gill Farrar, Andrew Stephens et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 211
Dementia prevention in memory clinics: recommendations from the European task force for brain health servicesGiovanni B. Frisoni, Bruno Dubois, Daniele Altomare et al.|The Lancet Regional Health - Europe|2023Cited by 181
PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future DirectionsJennifer Le Guévelou, Thomas Zilli, Vérane Achard et al.|Frontiers in Oncology|2021Cited by 12